Glenmark Pharmaceuticals ltd — Capital/Financing Update 2018

Oct 3, 2018

==> picture [34 x 32] intentionally omitted <==

==> picture [149 x 44] intentionally omitted <==

October 3, 2018

To, Dy. General Manager Department of Corporate Services, BSE Ltd., P. J. Towers, Dalal Street, Fort, Mumbai – 400 001

To,

The Manager – Listing, National Stock Exchange of India Ltd., Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051

Ref: Scrip Code: 532296

Ref: Scrip Name: GLENMARK

Dear Sirs,

SUB: ANNOUNCEMENT OF RESULTS OF THE REPURCHASE AS AT THE EXPIRATION TIME IN RESPECT OF THE COMPANY’S U.S.$200,000,000 2.00 PER CENT. RESETTABLE ONWARD STARTING EQUITY-LINKED SECURITIES DUE 2022

With respect to the above subject, please find enclosed herewith Announcement of Results of the Repurchase.

You are requested to take the same on record.

Thanking you

Yours faithfully, For Glenmark Pharmaceuticals Limited HARISH VINAYAK Digitally signed by HARISH VINAYAK KUBER KUBER Date: 2018.10.03 10:12:12 +05'30' Harish Kuber Company Secretary Compliance Officer

Tel: 4018 9999 / 4018 9879 Fax: 4018 9986 (Legal & Secretarial Dept.)

Glenmark Pharmaceuticals Ltd. Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA (THE “UNITED STATES”), INDIA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.

3 OCTOBER 2018

==> picture [42 x 42] intentionally omitted <==

Glenmark Pharmaceuticals Limited

( a company incorporated with limited liability under the laws of the Republic of India )

(the Company )

ANNOUNCEMENT OF RESULTS OF THE REPURCHASE AS AT THE EXPIRATION TIME IN RESPECT OF THE COMPANY’S U.S.$200,000,000 2.00 PER CENT. RESETTABLE ONWARD STARTING EQUITY-LINKED SECURITIES DUE 2022

(ISIN: XS1426780125; COMMON CODE: 142678012) ( the “BONDS”)

The Company announces today the results of its repurchase of Bonds through J.P. Morgan Securities plc and MUFG Securities Asia Limited (the Dealer Managers ) in the open market (the Transaction ).

The Transaction was announced on 28 September 2018 and expired at 5:00 p.m. (London time) on 28 September 2018 (the Expiration Time ).

As at the Expiration Time, U.S.$86,500,000 in aggregate principal amount of the Bonds were purchased by the Dealer Managers pursuant to the Transaction (the Offered Bonds ).

On the Settlement Date, the Company will acquire the Offered Bonds from the Dealer Managers. Offered Bonds will be cancelled by the Company on the Settlement Date. Following settlement of the Transaction, U.S.$113,500,000 in aggregate principal amount of Bonds will remain outstanding.

Bondholders who have questions regarding the Transaction may contact the Dealer Managers.

DEALER MANAGERS

J.P. Morgan Securities plc 25 Bank Street Canary Wharf London E14 5JP United Kingdom

Telephone: +852 2800 1272 Email: mahesh.ahlawat@jpmorgan.com

MUFG Securities Asia Limited

11/F, AIA Central 1 Connaught Road Central Hong Kong

Telephone: +44 20 7577 4048/4218 (International)

Telephone: +65 6232 7632 (Asia) Attention: Liability Management Group Email: DCM-LM@int.sc.mufg.jp

Disclaimer : This announcement contains important information which should be read carefully.

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required by each of the Company and the Dealer Managers to inform themselves about and to observe any such restrictions.

2